Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M MacDonald

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
British Journal of Clinical Pharmacology|August 29, 2006
Influence of a single dose of 20 mg tadalafil, a phosphodiesterase 5 inhibitor, on ambulatory blood pressure in subjects with hypertensionDean Patterson, Gordon T McInnes, John Webster, et al.
BMJ Open|February 1, 2013
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)Thomas M Macdonald, Isla S Mackenzie, Li Wei, et al.
BMJ Open|June 9, 2018
Protocol for assessment of sleep quality and duration in the Treatment In Morning versus Evening (TIME) study: a randomised controlled trial using online patient-reported outcome measuresAmy Rogers, Ian Morrison, David A Rorie, et al.
Respiratory Research|November 20, 2014
Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysisRob W Flynn, Thomas M MacDonald, Adrian Hapca, et al.
Lancet (London, England)|January 18, 2011
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trialMorris J Brown, Gordon T McInnes, Cheraz Cherif Papst, et al.
British Journal of Clinical Pharmacology|October 14, 2016
Spironolactone use and risk of incident cancers: a retrospective, matched cohort studyIsla S Mackenzie, Steven V Morant, Li Wei, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2006
Vitamin A and lung function in CFFiona K Aird, Stephen A Greene, Simon A Ogston, et al.
Cardiovascular Therapeutics|March 27, 2010
Systematic review of observational research studying the long-term use of antithrombotic medicines following intracerebral hemorrhageRobert W V Flynn, Thomas M MacDonald, Gordon D Murray, et al.
Pharmacoepidemiology and Drug Safety|June 30, 2011
Managing security and privacy concerns over data storage in healthcare researchIsla S Mackenzie, Brian J Mantay, Patrick G McDonnell, et al.
Pharmacoepidemiology and Drug Safety|March 6, 2003
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular diseaseWayne A Ray, Thomas M MacDonald, Daniel H Solomon, et al.
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
British Journal of Clinical Pharmacology|August 29, 2006
Influence of a single dose of 20 mg tadalafil, a phosphodiesterase 5 inhibitor, on ambulatory blood pressure in subjects with hypertensionDean Patterson, Gordon T McInnes, John Webster, et al.
BMJ Open|February 1, 2013
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)Thomas M Macdonald, Isla S Mackenzie, Li Wei, et al.
BMJ Open|June 9, 2018
Protocol for assessment of sleep quality and duration in the Treatment In Morning versus Evening (TIME) study: a randomised controlled trial using online patient-reported outcome measuresAmy Rogers, Ian Morrison, David A Rorie, et al.
Respiratory Research|November 20, 2014
Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysisRob W Flynn, Thomas M MacDonald, Adrian Hapca, et al.
Lancet (London, England)|January 18, 2011
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trialMorris J Brown, Gordon T McInnes, Cheraz Cherif Papst, et al.
British Journal of Clinical Pharmacology|October 14, 2016
Spironolactone use and risk of incident cancers: a retrospective, matched cohort studyIsla S Mackenzie, Steven V Morant, Li Wei, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2006
Vitamin A and lung function in CFFiona K Aird, Stephen A Greene, Simon A Ogston, et al.
Cardiovascular Therapeutics|March 27, 2010
Systematic review of observational research studying the long-term use of antithrombotic medicines following intracerebral hemorrhageRobert W V Flynn, Thomas M MacDonald, Gordon D Murray, et al.
Pharmacoepidemiology and Drug Safety|June 30, 2011
Managing security and privacy concerns over data storage in healthcare researchIsla S Mackenzie, Brian J Mantay, Patrick G McDonnell, et al.
Pharmacoepidemiology and Drug Safety|March 6, 2003
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular diseaseWayne A Ray, Thomas M MacDonald, Daniel H Solomon, et al.
Pageof 16